The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

Arthritis and Rheumatism

Volumn 43, Issue 1, 2000, Pages 155-163

  Schellekens, Gerard A ^a   Visser, Hendrik ^b   De Jong, Ben A W ^a   Van Den Hoogen, Frank H J ^c   Hazes, Johanna M W ^b   Breedveld, Ferdinand C ^b   Van Venrooij, Walther J ^a,c  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CITRULLINE;

ADOLESCENT; ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PEPTIDE ANALYSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BACTERIAL INFECTIONS; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RHEUMATOID FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 0034091322     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3     Document Type: Article

References (30)

1. Smolen JS. Autoantibodies in rheumatoid arthritis. In: van Venrooij WJ, Maini RN, editors. Manual of biological markers of disease. Dordrecht (The Netherlands): Kluwer Academic Publishers; 1996. p. C1.1/1-18.
2. Visser H, Gelinck LBS, Kampfraath AH, Breedveld C, Hazes JMW. Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assay in rheumatoid arthritis. Ann Rheum Dis 1996;55:157-61.
3. Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS. Autoantibody to the nuclear antigen RA33; a marker for early rheumatoid arthritis. Br J Rheumatol 1993;32:199-203.
4. Deprés N, Boire G, Lopez-Longo FJ, Ménard HA. The SA system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 1994;21:1027-33.
5. Bläss S, Haferkamp C, Specker C, Schwochau M, Schneider M, Schneider EM. Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigcn. Ann Rheum Dis 1997;56:317-22.
6. Lackner KJ, Schlosser U, Lang B, Schmitz G. Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera. Br J Rheumatol 1998;37:1164-71.
7. Nienhuis RLF, Mandema EA. A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor. Ann Rheum Dis 1964;23:302-5.
8. Hoet RM, van Venrooij WJ. The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. In: Smolen J, Kalden J, Maini RN, editors. Rheumatoid arthritis. Berlin: Springer-Verlag; 1992. p. 299-318.
9. Hoet RM, Boerbooms AMT, Arends M, Ruiter DJ, van Venrooij WJ. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the pcrinuclcar factor and profilaggrin. Ann Rheum Dis 1991;50:611-8.
10. Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, et al. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol 1998;26:7-13.
11. Bläss S, Meier C, Vohr HW, Schwochau M, Specker C, Burmester GR. The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies. Ann Rheum Dis 1998;57:220-5.
12. Simon M, Girbal E, Sebbag M, Gomés-Daudrix V, Vincent C, Salema G. et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993;92:1387-93.
13. Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Durieux JJ, et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95:2672-9.
14. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LB, van Venrooij WJ. Citrullinc is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
15. Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM. Protein unfolding by peptidylarginine deiminase: substrate specificity and structural relationship of the natural substrates trichohyalin and filaggrin. J Biol Chem 1996;271:30709-17.
16. Girbal-Neuhauser E, Durieux JJ. Arnaud M, Dalbon P, Sebbag M, Vincent C, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are post-translationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94.
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Otten HG, Daha MR, de Rooij HH, Breedveld FC. Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system. Br J Rheumatol 1989;28:310-6.
19. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologie abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
20. Van der Heijde DM, van Riel PL, Nuver-Zwart HH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8.
21. Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux J-J, Cantagrel A, et al. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol 1998;25:838-46.
22. Slack SL, Mannik M, Dale BA. Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol 1998;25:847-51.
23. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, et al. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol 1998;115:294-302.
24. Dagenias P, Desprez P, Albert J, Escher E. Direct covalent attachment of small peptide antigens to enzyme-linked immunosorbent assay plates using radiation and carbodiimide activation. Anal Biochem 1994;222:149-55.
25. Søndergård-Andersen J, Lauritzen E, Lind K, Holm A. Covalently linked peptides for enzyme-linked immunosorbent assay. J Immunol Methods 1990;131:99-104.
26. Li SC, Kim PK, Deber CM. Manipulation of peptide conformations by fine-tuning of the environment and/or the primary sequence. Biopolymers 1995;35:667-75.
27. Williamson MP, Hall MP, Handa BK. Secondary structure of a herpes simplex virus glycoprotein D antigenic domain. Int J Pept Protein Res 1986;27:562-8.
28. Dyson HJ, Wright PE. Antigenic peptides. FASEB J 1995;9:37-42.
29. Dorow DS, Shi PT, Carbone FR, Minasian E, Todd PEE, Leach SJ. Two large immunogenic and antigenic peptides and the effect of cyclisalion. Mol Immunol 1985;22:1255-64.
30. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.